The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Statins for people at low risk of cardiovascular disease – Authors' reply
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Statin therapy has been appropriately emphasized in the current US and European guidelines as the primary treatment for LDL-C reduction because of strong evidence of reduced safety, efficacy and events [8, 9].”
From Effects of aerobic exercise on lipids and lipoproteins (2017) · cites this paper as [9]
In the citing paper
“Lowering serum cholesterol can help reduce the risk of coronary heart disease (CHD).”
From Effects of aerobic exercise on lipids and lipoproteins (2017) · cites this paper as [9]
Citations
Cites
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833
Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Collaborative, H. P. S. (2006) · BMJ · doi:10.1136/bmj.38993.731725.be · Cited by 109
Prepared by the Cholesterol Treatment Trialists' (CTT) Collaboration (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80744-9 · Cited by 101
Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels
Heart Protection Study Collaborative Group (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.808469 · Cited by 72
Cited by
Sorted by citations
Items 101–146 of 146
Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials
Chen, W., Huang, Z., Bi, M., Xu, X., & Zhao, N. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0439-0 · Cited by 6
Ross, S. M. (2016) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000192 · Cited by 6
Petrov, I. S., Postadzhiyan, A., Vasilev, D., Kasabov, R., Tokmakova, M. P., Nikolov, F. P., Istatkov, V., Zhao, B., Mutafchiev, D., & Petkova, R. T. (2021) · Advances in Therapy · doi:10.1007/s12325-020-01608-3 · Cited by 6
Cardiovascular Disease Prevention: Matching Evidence-Based Algorithms With Individualized Care
Madanieh, R., Hasan, R. K., Anusionwu, O. F., Blumenthal, R. S., & Blaha, M. J. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.3 · Cited by 5
Li, Y., Wang, S., Liu, L., Cai, H., Huang, Y., Gao, M., Zhang, X., Wu, Q., & Qiu, G. (2025) · Advanced Science · doi:10.1002/advs.202413491 · Cited by 6
Application of New Cholesterol Guidelines to the Korean Adult Diabetic Patients
Kim, B. K., Kim, H. C., Ha, K. H., & Kim, D. J. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.11.1612 · Cited by 5
Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes
Ganda, O. P., & Mitri, J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0790-1 · Cited by 6
Statins and Elderly: From Clinical Trials to Daily Practice
Verdoia, M., Galasso, G., Filardi, P. P., & Luca, G. D. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180628145723 · Cited by 5
Zhao, X., Liu, C., Zhou, P., Sheng, Z., Li, J., Zhou, J., Chen, R., Wang, Y., Chen, Y., Song, L., et al. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s358761 · Cited by 4
Cho, K. H., & Jeong, M. H. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.3.362 · Cited by 4
Cardiac Rehabilitation for Women
Engberding, N., & WENGER, N. K. (2013) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-013-0306-0 · Cited by 4
Jackson, R. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000089 · Cited by 4
Su, M., Si, Y. J., Guo, Q., Yang, M., Chen, X., Lin, J., & Fang, D. Z. (2018) · Biochemical Genetics · doi:10.1007/s10528-018-9890-5 · Cited by 4
Hochholzer, W., & Giugliano, R. P. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0290-8 · Cited by 3
Zheng, X., Han, X., Xu, H., Ai, J., Yang, L., & Wei, Q. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1068-6 · Cited by 3
Opposing View: A Blind Faith in Meta-Analyses in Academia Could Be a Threat to Public Health
Bae, J. H. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.3.308 · Cited by 3
Hur, S. (2014) · Korean Journal of Medicine · doi:10.3904/kjm.2014.87.2.142 · Cited by 2
Pharmacological lipid lowering for prevention of cardiovascular disease in older adults
Wiklund, O., Pirazzi, C., & Romeo, S. (2013) · Clinical Practice · doi:10.2217/cpr.13.83 · Cited by 2
Prioritizing health outcomes in a limited world
Qureshi, N., Minhas, R., & Wierzbicki, A. S. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000170 · Cited by 2
Graham, I. M., & Catapano, A. L. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0857-7 · Cited by 2
Strategies for the use of nonstatin therapies
Pirillo, A., Norata, G. D., & Catapano, A. L. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000459 · Cited by 2
Update Fettstoffwechselstörungen
Parhofer, K. G. (2013) · Der Internist · doi:10.1007/s00108-013-3335-3 · Cited by 2
Cha, J., Hong, S. J., Lim, S., Kim, J. H., Joo, H. J., Park, J. H., Yu, C. W., Lim, D., Kim, J., Jeong, J., et al. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0036 · Cited by 2
Huded, C. P., & Prasad, V. K. (2015) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-015-0139-y · Cited by 2
Kameda, A., Nakamura, A., Kondo, Y., Kimura, M., & Terauchi, Y. (2017) · Diabetology International · doi:10.1007/s13340-017-0328-9 · Cited by 2
Statins for primary prevention: identifying low-risk individuals
Huang, Y., Huang, Y., & Wu, Y. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.80-c1 · Cited by 2
What do high blood resistin levels mean for patients on statin therapy?
Rashid, S. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.176 · Cited by 2
The new ACCF/AHA guidelines on the treatment of dyslipidemia: pros
Caterina, R. D. (2014) · Internal and Emergency Medicine · doi:10.1007/s11739-014-1159-3 · Cited by 1
Statins for Treating Stable Angina: Can Statins Improve the Plaque Morphology and angina?
Lee, C. W., & Park, S. (2013) · Future Cardiology · doi:10.2217/fca.12.88 · Cited by 1
Kassam, N., Surani, S., Hameed, K., Aghan, E., Mayenga, R., Matei, I., Jengo, G., Bakshi, F. A., Mbithe, H., Orwa, J., et al. (2023) · Patient Related Outcome Measures · doi:10.2147/prom.s405392 · Cited by 1
Effect of simvastatin treatment on plasma visfatin levels in obese women
Petreanu, M., Eleuterio, N. M., Bosco, A., & Sandrim, V. C. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.911273 · Cited by 1
Lee, H., Ahn, H., Park, H. E., Han, D., Chang, H., Chun, E. J., Han, H., Sung, J., Jung, H. O., & Choi, S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1173289 · Cited by 2
Pharmacological Modulation of Small GTPases in Cardiovascular Diseases
Ferri, N. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000004 · Cited by 1
(2015) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.12.4.101corr1 · Cited by 1
Stärken und Grenzen randomisierter Studien zur Lipidtherapie
Windler, E. E. T., Klose, G., Parhofer, K. G., & Steinhagen‐Thiessen, E. (2014) · CardioVasc · doi:10.1007/s15027-014-0520-9
Weniger Herzerkrankungen, aber mehr Diabetesfälle?
Parhofer, K. G. (2012) · CardioVasc · doi:10.1007/s15027-012-0331-9
Brauchen alle Diabetiker Aspirin und Statine?
Parhofer, K. G. (2015) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-015-3031-4
Parhofer, K. G. (2016) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-016-7653-y
Dyslipidemia: Contemporary Therapy Options in Terms of Worldwide Guidelines
Djordjevic, D. B., Đorđević, A. D., & Lović, D. B. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00173-w
Cavallari, I., Filippis, A. D., Nobile, E., Veneziano, F. A., Melfi, R., Nusca, A., Ussia, G. P., & Grigioni, F. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00954-w
Pei, L., Xiao, H., Lai, F., Li, Z., Li, Z., Yue, S., Chen, H., Li, Y., & 曹筱佩 (2020) · Figshare · doi:10.6084/m9.figshare.13076676
Nazarzadeh, M., Pinho‐Gomes, A., Bidel, Z., Canoy, D., Dehghan, A., Smith Byrne, K., Bennett, D. A., Smith, G. D., & Rahimi, K. (2021) · Figshare · doi:10.6084/m9.figshare.14168440
Nazarzadeh, M., Pinho‐Gomes, A., Bidel, Z., Canoy, D., Dehghan, A., Smith Byrne, K., Bennett, D. A., Smith, G. D., & Rahimi, K. (2021) · Figshare · doi:10.6084/m9.figshare.14168434
Pei, L., Xiao, H., Lai, F., Li, Z., Li, Z., Yue, S., Chen, H., Li, Y., & 曹筱佩 (2020) · Figshare · doi:10.6084/m9.figshare.13076673
Nazarzadeh, M., Pinho‐Gomes, A., Bidel, Z., Canoy, D., Dehghan, A., Smith Byrne, K., Bennett, D. A., Smith, G. D., & Rahimi, K. (2021) · Figshare · doi:10.6084/m9.figshare.14168443
Xia, Y., Leung, K. S. M., & Zhao, J. (2026) · npj Cardiovascular Health · doi:10.1038/s44325-026-00121-w · Cited by 1
Metadata
- Authors
- Mihaylova, B., Emberson, J., Keech, A., Collins, R., & Baigent, C.
- Affiliations
- University of Oxford (GB)
- The University of Sydney (AU)
- Corresponding author
- Baigent, Colin
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 380
- Issue
- 9856
- Pages
- 1817-1818
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2034831662
- Cited by
- 146
- References
- 5
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 10 · 2020: 7 · 2019: 5 · 2018: 7 · 2017: 16 · 2016: 24 · 2015: 13 · 2014: 21 · 2013: 30 · 2012: 3
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- statins, low cardiovascular risk, LDL cholesterol lowering, major vascular events, coronary revascularization, atherosclerotic cardiovascular disease, all-cause mortality, cardiovascular risk assessment, meta-analysis bias, individual patient data meta-analysis, coronary artery disease, ischemic stroke, coronary death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
